Evidence map›Paper›PMID 33826797›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Light-Activation of DNA-Methyltransferases.

Jan Wolffgramm, Benjamin Buchmuller, Shubhendu Palei, Álvaro Muñoz-López, Julian Kanne, Petra Janning, Michal R Schweiger, Daniel Summerer

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Light-Activation of DNA-Methyltransferases.Angewandte Chemie (International ed. in English) · 2021
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jan WolffgrammFaculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn Str. 4a, 44227, Dortmund, Germany.
Benjamin BuchmullerFaculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn Str. 4a, 44227, Dortmund, Germany.
Shubhendu PaleiFaculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn Str. 4a, 44227, Dortmund, Germany.
Álvaro Muñoz-LópezFaculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn Str. 4a, 44227, Dortmund, Germany.
Julian KanneDepartment of Epigenetics and Tumor Biology, Medical Faculty, University of Cologne, Kerpener Str. 62, 50937, Köln, Germany.
Petra JanningMax-Planck-Institute for Molecular Physiology, Otto-Hahn-Str. 11, 44227, Dortmund, Germany.
Michal R SchweigerDepartment of Epigenetics and Tumor Biology, Medical Faculty, University of Cologne, Kerpener Str. 62, 50937, Köln, Germany.
Daniel SummererFaculty of Chemistry and Chemical Biology, TU Dortmund University, Otto-Hahn Str. 4a, 44227, Dortmund, Germany.ORCID 0000-0002-3019-7241
TU Dortmund University · DEUniversity of Cologne · DEMax Planck Institute of Molecular Physiology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Methylcytosine (5mC), the central epigenetic mark of mammalian DNA, plays fundamental roles in chromatin regulation. 5mC is written onto genomes by DNA methyltransferases (DNMT), and perturbation of this process is an early event in carcinogenesis. However, studying 5mC functions is limited by the inability to control individual DNMTs with spatiotemporal resolution in vivo. We report light-control of DNMT catalysis by genetically encoding a photocaged cysteine as a catalytic residue. This enables translation of inactive DNMTs, their rapid activation by light-decaging, and subsequent monitoring of de novo DNA methylation. We provide insights into how cancer-related DNMT mutations alter de novo methylation in vivo, and demonstrate local and tuneable cytosine methylation by light-controlled DNMTs fused to a programmable transcription activator-like effector domain targeting pericentromeric satellite-3 DNA. We further study early events of transcriptome alterations upon DNMT-catalyzed cytosine methylation. Our study sets a basis to dissect the order and kinetics of diverse chromatin-associated events triggered by normal and aberrant DNA methylation.

Indexed as

Light5-MethylcytosineBiocatalysisCell Line, TumorDNA (Cytosine-5-)-MethyltransferasesDNA MethylationHEK293 CellsHumansMutationTranscriptome5-MethylcytosineDNA (Cytosine-5-)-MethyltransferasesDNA methyltransferasesepigeneticsgenetic code expansionoptochemical biology

Identifiers

PMID33826797
PMCPMC8251764
OpenAlexW3147684442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.